Tasly Pharmaceutical Group Co., Ltd.
Premier conglomérat pharmaceutique chinois spécialisé dans la médecine traditionnelle chinoise et les cartes…
Conglomérat pharmaceutique chinois de premier plan spécialisé dans la médecine traditionnelle chinoise et les médicaments cardio-cérébrovasculaires ; produits distribués dans plus de 40 pays. Exploite des centres de R&D et des usines de fabrication certifiées selon les normes internationales GMP.
- Type
- brand seeking distribution
- Location
- Tianjin, China
- Founded
- 1994
- Website
- tasly.com
- Categories
- Fournitures médicales et de santé, Compléments et bien-être
- Markets
- Chine, États-Unis, Allemagne, Australie, Canada
Verified facts
- domain-registered (green), checked 2026-08-12 Domain registry record
- sanctions-clear (green), checked 2026-08-12 OpenSanctions
- debarment-clear (green), checked 2026-08-12 OpenSanctions
- facility-registered (green), checked 2026-08-19 BPOM (Indonesian Food and Drug Authority), public register of manufacturing facilities behind product registrations (Sarana)
- gmp-certified (green), checked 2020-12-09 EudraGMDP, EU register of GMP certificates (EMA)
Claimed certifications
- ISO 9001, Quality Management IAF CertSearch
- Good Manufacturing Practice
- ISO 14001, Environmental Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)